Krsnaa Diagnostics shares jumped more than 3% in morning trade after the company agreed to acquire 23.53% stake in Apulki Healthcare Private Limited. Krsnaa Diagnostics Limited will pay a cash consideration. As part of the consideration, an undisclosed value is paid to None of Apulki Healthcare Private Limited.
The transaction is subject to the approval of an offer by the acquirer board. The board approved the arrangement. The transaction’s expected completion is September 25, 2024 to December 25, 2024.
As of 9:47 am, Krsnaa Diagnostics were trading 2.18 % higher at Rs 856.50 on the NSE.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
